Veterinary Reference Laboratory Market to Reach USD 8.55 Billion by 2032, Driven by Advanced Diagnostics and Rising Animal Healthcare Demand

Market Estimation, Growth Drivers, and Opportunities

The global Veterinary Reference Laboratory Market was valued at USD 5.42 billion in 2025 and is projected to reach approximately USD 8.55 billion by 2032, expanding at a compound annual growth rate (CAGR) of 6.73% from 2026 to 2032. Veterinary reference laboratories provide specialized diagnostic services, including clinical pathology, clinical chemistry, hematology, immunodiagnostics, and disease testing, helping veterinarians identify health conditions and make informed treatment decisions.

Market growth is supported by rising companion-animal ownership, increasing expenditure on veterinary care, and growing awareness of preventive healthcare. The rising incidence of infectious and zoonotic diseases is also increasing demand for accurate diagnostic testing, surveillance, and early intervention. Livestock health monitoring and food-safety requirements further strengthen demand for laboratory services. Opportunities are emerging in molecular diagnostics, automated testing, digital pathology, artificial intelligence (AI)-assisted analysis, and specialist consultations. Laboratories that improve diagnostic accuracy, shorten turnaround times, and expand access to advanced tests are positioned to benefit from growing demand across companion-animal and production-animal healthcare.

* Access Exclusive Industry Data: https://www.maximizemarketresearch.com/request-sample/84180/ 

US Market Trends and Investment

The United States remains a major market for veterinary reference laboratory services, supported by substantial pet-care spending, established veterinary infrastructure, and demand for sophisticated diagnostic testing. In May 2025, Zoetis announced the opening of its newest and largest diagnostics reference laboratory in Louisville, Kentucky. The 32,000-square-foot facility, located at UPS Healthcare Labport near UPS Worldport, was designed to improve specimen logistics, testing capacity, and delivery of results to veterinary clinics. The laboratory supports a broad range of services, including chemistry, hematology, microbiology, cytology, and histology. In March 2025, Antech Diagnostics also introduced its trūRapid FOUR test for screening dogs for selected vector-borne diseases. These developments demonstrate how investments in laboratory infrastructure, specimen transport, and accessible diagnostic technologies are helping strengthen the US veterinary diagnostics ecosystem.

Market Segmentation: Largest-Share Segments

By animal type, companion animals dominated the market in 2025, accounting for approximately 65.45% of global revenue. Rising pet ownership, greater spending on veterinary visits, and demand for routine wellness testing and advanced disease detection support this segment's leadership.

By application, clinical pathology held the largest revenue share. Clinical pathology laboratories perform widely used tests such as complete blood counts, blood chemistry, urinalysis, coagulation analysis, and cytology. These tests support routine health checks, diagnosis, treatment monitoring, and assessment of chronic conditions, making them essential to veterinary practices.

Key players
IDEXX Laboratories, Inc.
Antech Diagnostics, Inc.
Zoetis Reference Laboratories
Mars, Incorporated
SYNLAB Group
Eurofins Scientific SE
GD Animal Health
NEOGEN Corporation
Heska Corporation
Laboklin GmbH & Co. KG
Virbac
VCA, Inc.
NationWide Laboratories
Thermo Fisher Scientific, Inc.
ProtaTek International, Inc.
CVS Group plc
Marshfield Labs
Phoenix Lab
Texas A&M Veterinary Medical Diagnostic Laboratory
Greencross Vets
Inovie Vet
Vaxxinova GmbH
Asia Veterinary Diagnostics
Veterinary Pathology Group
Animal and Plant Health Agency

Competitive Analysis

Competition is shaped by diagnostic accuracy, breadth of test menus, laboratory networks, turnaround time, technology investment, and relationships with veterinary professionals. Leading companies identified in the market include IDEXX Laboratories, Antech Diagnostics, Zoetis Reference Laboratories, Mars, and SYNLAB Group.

IDEXX Laboratories, Inc. competes through its reference-laboratory network, diagnostic instruments, and connected software. Its 2025 innovation programme included the launch of IDEXX Cancer Dx in the United States and Canada for early detection of canine lymphoma, broadening access to veterinary oncology diagnostics.

Antech Diagnostics, Inc., part of Mars Petcare's science and diagnostics business, expanded its diagnostic offering in March 2025 with trūRapid FOUR. The test screens for selected canine vector-borne diseases and is designed to simplify workflows for veterinary teams.

Zoetis Reference Laboratories strengthened its US network with the Louisville laboratory in May 2025. Its investment in laboratory capacity and specimen logistics highlights the importance of efficient sample processing and timely results.

Mars, Incorporated, through its veterinary and diagnostics businesses, benefits from an integrated animal-health ecosystem connecting veterinary services, diagnostic testing, and clinical expertise. Continued development of testing options and laboratory capabilities can help address demand for accessible and comprehensive animal healthcare.

SYNLAB Group is a major laboratory diagnostics provider included among the market's profiled competitors. Its broader laboratory expertise provides a platform for participation in specialized testing markets, although veterinary-specific investment or market-share figures should not be assumed without separate confirmation.

Regional Analysis: United States, United Kingdom, Germany, France, Japan, and China

United States: The country benefits from high companion-animal healthcare expenditure, established veterinary networks, and investment in laboratory infrastructure. Public-sector disease surveillance and animal-health programmes also support the need for reliable testing.

United Kingdom: Veterinary laboratory demand is supported by established veterinary services and the need to monitor animal diseases. Zoetis announced its acquisition of Veterinary Pathology Group in November 2025, expanding its diagnostics presence in the UK and Ireland.

Germany: Demand is supported by veterinary healthcare infrastructure, livestock-health requirements, and European animal-disease surveillance frameworks. Laboratory services play an important role in diagnosis, herd monitoring, and food-chain biosecurity.

France: A developed veterinary sector and livestock production create demand for companion-animal diagnostics and testing related to animal health and food safety. Veterinary laboratories can benefit from investments in specialist testing and faster diagnostic workflows.

Japan: Demand is supported by companion-animal healthcare and the need for accurate diagnosis in an established veterinary-care system. Automation and advanced testing can help laboratories improve operational efficiency.

China: Large-scale livestock production, growing companion-animal care, and attention to animal disease control create opportunities for diagnostic laboratories. Investment in testing capacity and modern laboratory technology can support disease monitoring and biosecurity.

The available market estimate identifies North America as the leading region, with 39% of global market share in 2025. Comparable individual country-level shares for the six countries above are not provided in the referenced market data, so they have not been estimated.

Conclusion

The Veterinary Reference Laboratory Market is positioned for sustained growth as animal healthcare increasingly prioritizes early diagnosis, preventive care, and accurate disease monitoring. Companion-animal testing and clinical pathology currently provide the strongest demand base, while molecular diagnostics, AI-assisted analysis, automation, and specialist laboratory services offer further opportunities. Companies that invest in efficient sample logistics, expanded testing menus, digital workflows, and reliable results can strengthen their competitive position. At the same time, surveillance of zoonotic diseases and improved livestock health monitoring are likely to remain important drivers. Continued innovation and broader access to advanced diagnostic services will be central to the market's development through 2032.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.

Contact Maximize Market Research

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 sales@maximizemarketresearch.com